35 resultados.
In 2020, tourism in the country declined to a level last seen in 1996, when the landmark first million international visitors arrived, and in 2021 only 356,453 vacationers visited
The fire fighters who worked to extinguish the fire in the Fuel Storage Base in Matanzas, including those who died in the line of duty, will be honored for their heroism
When, at the end of July 2021, the anti-COVID-19 mass immunization with nationally produced vaccines created by our scientists began in Cuba, the daily positive cases of SARS-COV-2 amounted to 9,000, with thousands of accumulated deaths and more than 40,000 active patients with the virus, in the midst of a complex epidemiological situation that hit Cuban families.
Clinical studies showed the Cuban vaccines against COVID-19 have over 90% efficacy.
Expanding into Latin America is essential for the Cuban tourism industry to reach its goal of 3.5 million international visitors this year.
The Family Code draft plans to extend the age to be adopted up to 18 years old and to widen the age gap among adopters and adopted ones, among other novelties.
The vaccine candidate Mambisa - developed by the Center for Genetic Engineering and Biotechnology (CIGB) - is currently in the final stages of clinical trials and, based on the results obtained in the analyses, will apply to the Center for State Control of Medicines, Equipment and Medical Devices for authorization for emergency use as a booster dose in the next few weeks.
Faced with the increase of emerging diseases in the world, science advocates paying the same attention to human, animal and plant health.
In just one year of the COVID-19 battle, Cuba has traveled to every continent offering support to 40 countries
A Phase I clinical trial based on the treatment of lung injury with autologous stem cells (derived from the patient's own blood) in COVID-19 patients with lung injury demonstrated the safety and efficacy of this therapy in the indication studied
